[1] Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005 Mar 10;352(10):997-1003.
[2] American Brain Tumour Association, Online http://www.abta.org/about-us/news/brain-tumor-statistics/, Last accessed March 28, 2018
[3] Brain Foundation, Online. http://brainfoundation.org.au/wp-content/uploads/2015/05/Khanna-Anchit-Glioblastoma-2.pdf Last accessed March 28, 2018
[4] Schapira, Anthony H.V. (2007). Neurology and clinical neuroscience. Philadelphia: Mosby Elsevier. p. 1336
[5] Gallego, O (August 2015). “Nonsurgical treatment of recurrent glioblastoma”. Current oncology (Toronto, Ont.). 22 (4): e273?81
Home Hegi ME, Diserens AC, Gorlia T
